학술논문

176. The tumor necrosis factor-alpha antagonist infliximab reduces depressive symptoms in patients with treatment resistant depression and high inflammation
Document Type
Abstract
Source
In Brain Behavior and Immunity September 2012 26 Supplement 1:S49-S49
Subject
Language
ISSN
0889-1591